Varun Pandey, PhD
Director, Medical Information & Medical Affairs Strategic Operations - India
Expertise:
Varun is a seasoned professional with over a decade of expertise in scientific research and medical communications, spanning both academia and the pharmaceutical industry. His extensive background includes leadership roles in scientific publications and medical information content development. Varun has played a pivotal role as a medical reviewer for a diverse range of medical communication deliverables, serving top pharmaceutical clients across various therapeutic areas. His commitment to maintaining high precision, superior quality, data accuracy, scientific rigor, language consistency, and overall aesthetic appeal is unwavering. Moreover, Varun’s extensive experience in leading scientific writing teams demonstrates his ability to orchestrate data fact-checking and medical reviews efficiently. His strategic acumen shines through in resource allocation and meticulous planning to ensure the timely delivery of review services, synchronized with major global conferences like ASCO, ESMO, AHA, ADA, ACC, and ERS.
Articles by Varun Pandey, PhD
Considerations for the Development of Interactive / Innovative Medical Information Content – Insights from a Service Provider
The creation of high-quality, customer-centric medical information (MI) content accessible through various data dissemination channels is crucial. EVERSANA, a provider of global MI contact center services, has embarked on developing more interactive MI content. This initiative involves converting traditional SRDs and FAQs into engaging and innovative formats by identifying considerations essential for this format of […]
Current Trends in Medical Review of Promotional and Non-Promotional Materials
Medical Information (MI) plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients/caregivers and ensuring pharmaceutical products’ safe, effective, and appropriate use. However, MI teams often have other important responsibilities beyond the scope of traditional MI services. EVERSANA conducted a survey in 2023 to assess current trends and to better understand Medical […]
Considerations for Globalization of Medical Information Services: A Service Partner Perspective
This poster details the considerations for globalizing medical information (MI) services. Traditionally, pharmaceutical companies began in one geographical region before expanding, but evolving regulations and research priorities for rare diseases, oncology/hematology, immunology, and cell and gene therapy have led to simultaneous global regulatory filings. To streamline operations and maintain control, these companies partner with global […]